1. DAmbrosi E, Casa B, Bompani G, et al. Glucosamine sulphate: a controlled clinical investigation in arthrosis. Pharmatherapeutica 1981;2(8):5048.
2. Giordano N, Nardi P, Senesi M, et al. The efficacy and safety of glucosamine sulfate in the treatment gonarthritis. Clin Ter 1996;147:99-105.
3. Tapadinhas MJ, Rivera IC, Bignamini AA. Oral glucosamine sulphate in the management of arthrosis: report on a multi-centre open investigation in Portugal. Pharmtherapeutica 1982;3:157-68.
4. Altman RD, Lozada CJ. Practice guidelines in the management of osteoarthritis. Osteoarthritis Cartila 1998;6(Suppl A):22-4 (review).
5. Felson DT, Zhang Y, HanNan MT, et al. Risk factors for incident radiographic knee osteoarthritis in the elderly: the Framingham Study. Arthritis Rheum 1997;40:728-33.
6. Felson DT, Zhang Y, Anthony JM, et al. Weight loss reduces the risk for symptomatic knee osteoarth in women. The Framingham Study. Ann Intern Med 1992;116:535-9.
7. Taylor MR. Food allergy as an etiological factor in arthropathies: a survey. J Internal Acad Prev Med 1983;8:28-38 (review).
8. Childers NF, Margoles MS. An apparent relation of nightshades (Solanaceae) to arthritis. J Neurol Ort Med Surg 1993;14:227-31.
9. Childers NF. A relationship of arthritis to the solanaceae (nightshades). J Internal Acad Pre Med 1982;Nov:31-7.
10. Reichelt A, Forster KK, Fischer M, et al. Efficacy and safety of intramuscular glucosamine sulfate is osteoarthritis of the knee. Arzneimittelforschung 1994;44:75-80.
11. Drovanti A, Bignamini AA, Rovati AL. Therapeutic activitiy of oral glucosamine sulfate in osteoarthrit placebo controlled doubleblind investigation. Clin Ther 1980;3(4):260-72.
12. Vaz AL. Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate the management of osteoarthritis of the knee in outpatients. Curr Med Res Opin 1982;8(3):145-9.
13. Pujalte JM, Llavore EF, Ylescupidez FR. Double-blind clinical evaluatin of oral glucosamine sulphate the basic treatment of osteoarthrosis. Curr Med Res Opin 1980;7(2):110-4.
14. Rindone RP, Randomized controlled trial of glucosamine for treating osteoarthritis of the knee. West Med 200;172:91-4.
15. Qiu GX, Gao SN, Giacovelli G, et al. Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthiritis. Arzneimittelforschung 1998;48:469-74.

   

1. Marsh AG, Sanchez TV, Chaffee FL, et al. Bone mineral mass in adult lacto-ovo vegetarian and omnivorous women. J Am Deit Assoc 1983;37:453-6.
2. Hunt IF, Murphy NJ, Henderson C, et al. Bone mineral content in postmenopausal women: comparison omnivorous males. Am J Clin Nutr 1989;50:517-23.
3. Lloyd T, Schaeffer JM, Walker MA, Demers LM. Urinary hormonal concentrations and spinal bone densities of premenopausal vegetarian and nonvegetarian women. Am J Clin Nutr 1991;54:1005-10.
4. Tesar R, Notelovitz M, Shim E, et al. Axial and peripheral bone density and nutrient intakes of postmenopausal vegetarian and omnivorous women. Am J Clin Nutr 1992;56:699-704.
5. Tylavsky FA, Anderson JJ. Dietary factors in bone health of elderly lactoovovegetarian and omnivorous women. Am J Clin Nutr 1988;48(3 Suppl):842-9.
6. Lau EMC, Kwok T, Woo J, Ho SC. Bone mineral density in Chinese elderly female vegetarians, vegan lacto-vegetarians and omnivores. Eur J Clin Nutr 1998;52:60-4.
7. Tkatch L, Rapin CH, Rizzoli R, et al. Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. J Am Coll Nutr 1992;11:519-25.
8. Kerstetter JE, Allen LH. Dietary protein increases urinary calcium. J Nutr 1990;120:134-6.
9. Feskanich D, Willett WC, Stampfer JM, Colditz GA. Protein consumption and bone fractures in women J Epidemiol 1996;143:472-9.
10. Abelow BJ, Holford TR, Insogna KL. Cross-cultural associations between dietary animal protein and health fracture: a hypothesis. Calcif Tissue Int 1992;50:14-8.
11. Moriguti JC, Ferriolli E, Marchini JS. Urinary calcium loss in elderly men on a vegetable: animal (1:1) protein diet. Geronotology 1999;45:274-8.
12. Munger RG, Cerhan JR, Chiu BC. Prospective study of dietary protein intake and risk of hip fracute in postmenopausal women. Am J Clin Nutr 1999;69:147-52.
13. Mannan MT, Tucker K, Dawson-Hughes B, et al. Effect of dietary protein on bone loss in elderly men women: the Framingham Osteoporosis Study. J Bone Mineral Res 2000;15:2504-12.
14. Ellis FR, Holesh S, Ellis JW. Incidence of osteoporosis in vegetarians and omnivores. Am J Clin Nutr 1972;25:555-8.
15. Marsh AG, Sanchez TV, Midkelsen O, et al. Coritcal bone density of adult lacto-ovo-vegetarian and omnivorous women. J Am Deit Assoc 1980;76:148-51.

   

1. Forastiere F, Pistelli R, Sestini P, et al. Consumption of fresh fruit rich in vitamin C and wheezing symptoms in children. SIDRIA Collaborative Group, Italy (Italian Studies on Respiratory Disorders in Children and the Environment). Thorax 2000;55:283-8.
2. Javaid A, Cushley MJ, Bone MF. Effect of dietary salt on bronchial reactivity to histamine in asthma. 1988;297:454.
3. Bruney PG, Neild JE, Twort CH, et al. Effect of changing dietary sodim on the airway respone to histamine. Thorax 1989;44:36-41.
4. Carey OJ, Locke C, Cookson JB. Effect of alterations of dietary sodim on the severity of asthma in Thorax 1993;48:714-8.
5. Medical TC, Schmid AZ, Hacki M, Vetter W. Are asthmatics salt-sensitive? A preliminary controlled st Chest 1993;104:1138-43.
6. Gotshall RW, Micklegorough TD, Cordain. L. Dietary salt restriction imporves pulmonary function in exercise-induced asthma. Med Sci Soprts Exerc 2000;32:1815-9.
7. Fogarty A, Britton J. The role of diet in the aetiology of asthma. Clin Exp Allergy 2000;30:615-27.
8. Chiaramonte LT, Altman D. Food sensitivity in asthma: perception and reality. J Asthma 1991;28:5.
9. Blanc PD, Eisner MD, Israel L, Yelin EH. The association between occupation and asthma in general medical practice. Chest 1999;115:1259-64.
10. Mark A, Bjorksten B, Granstrom M. Immunoglobuin E and G antibodies two years after a booster dose an aluminium-absorbed or a fluid DT vaccine in relation to atopy. Pediatr Allergy Immunol 1997;8:83-7.
11. Mark A, Bjorksten B, Granstrom M. Odelram H, Granstrom M, Hedenskog S, et al. Immunoglubulin E and G responses to pertussis toxin booster immunization in relation to atopy, local reactions and aluminium content of the vaccines. Pedia Allergy Immunol 1994;5:118-23.
12. Aebischer I, Stadler BM. TH1-TH2 cells in allergic responses: at the limits of a concept. Adv Immunol 1996;61:341-403 (review).
13. Sen DK, Arora S, Gupta S, Sanyal RK. Studies of adrenergic mechanisms in relation to histamine sensitivity in children immunized with Bordetella pertussis vaccine. J Allergy Clin Immunol 1974;54:25-9.
14. Hurwitz EL, Morgenstern H. Effets of diphtheria-tetanus-pertussis or tetanus vaccination on allergie allergy-related respiratory symptoms among children and asolescents in the United States. J Manipulate Physiol Ther 2000;23:81-90.
15. Lindahl O, Lidnwall L, Spangberg A, et al. Vegan regimen with reduced mediction in the treatment of bronchial asthma. J Asthma 1985;22:45-55.

   

1. Gudmand-Hoyer E. The clinical significance of disaccharide maldigestion. Am J Clin Nutr 1994;59(3):41S.
2. Ledochowski M, Sperner-Unterweger S, Fuchs D. Lactose malabsorption is associated with early sign mental depression in females: a preliminary report. Digest Dis Sci 1998;43:2513-7.
3. Teuri U, Vappatalo H, Korpela R. Fructooligosaccharides and lactulose cause more symptoms in lactose maldigesters and subjects with pseudohypolactasia than in control lactose digesters. Am J Clin Nutr 1999;69:973-9.
4. Saltzman JR, Russell RM, Golner B, et al. A randomized trial of Lactobacillus acidophilus BG2FO4 to the lactose intolerance. Am J Clin Nutr 1999;69:140-6.

   

1. Cook JD, Noble NL, Morck TA, et al. Effect of fiber on nonheme iron absorption. Gastroenterology 1983;85:1354-8.
2. Mejia LA, Chew F. hematological effect of supplementing anemic children with vitamin a alone and in combination with iron. Am J Clin Nutr 1988;48:595-600.
3. Ajayi OA, Nnaji UR. Effect of ascorbic acid supplementation on haematological response and ascorbic status of young female adults. Ann Nutr Metab 1990;34:32-6.
4. Hunt JR, Gallagher SK, Johnson LK. Effect of ascorbic acid on apparent iron absorption by women with low iron stores. Am J Clin Nutre 1994;59:1381-5.
5. Schade SG, Cohen RJ, Conrad ME. Effect of hydrochloric acid on iron absorption. N Engl J Med 1968;279:672-4.
6. Bezwoda W, Chartlton R, Bothwell T, et al. The importance of gastric hydrochloric acid in the absorption of nonheme food iron. J Lab Clin Med 1978;92:108-16.
7. Grindulis H, Scott PH, Belton NR, Wharton BA. Combined deficiency of iron and vitamin D in Asian Toddlers. Arch Dis Child 1986;61:843-8.
8. Looker AC, Dallman PR, Carrol MD, et al. Prevalence of iron deficiency in the united States. JAMA 1997;277:973-6.
9. Sullivan JL. Stored iron and ischemic heart disease. Circulation 1992;86:1036 (editorial).
10. Morck TA, Lynch SR, Cook JD. Inhibition of food iron absorption by coffee. Am J Clin Nutr 1983;37:410-20.
11. Mehta SW, Pritchard ME, Stegman C. Contribution of coffee and tea to anemia among NHANES II participants. Nutr Res 1992;12:209-22.
12. Kaltwasser JP, Werner e, Shcalk K, et al. Clinical trial on the effect of regular tea drinking on iron accumulation in genetic heamochromatosis. Gut 1998;43:699-704.

   

1. Hernandez-Lopez C. Drugs do not only relieve male menopause. BMJ 2000;321:451 (letter).
2. Condra M, Morales A, Owen JA, et al. Prevalence and significance of tobacco smoking in impotence. Urology 1986;27:495-8.
3. Reiter WJ, Pycha A, Schatzl G, et al. Dehydroepiandrosterone in the treatment of erectile dysfunction prospective, double-blind randomized, placebo-controlled study. Urology 1999;53:590-5.
4. Zorgniotti AW, Lizza EF. Effect of large doses of the nitric oxide precursor, L-arginine, on erectile dysfunction. Int J Impotention Res 1994;6:33-6.
5. Chen J, Wollman Y, chernichovsky T, et al. Effect of oral administration of high dose nitric oxide donat arginine in men with organic erectile dysfunction: results of a double-blind, randomized study. BJU Int 1999;83:269-73.
6. Ernst E, Pittler MH. Yohimbine for erectile dysfunction: A systematic review and meta-analysis of randomized clinical trials. J Urol 1998;159:433-6.
7. Carey MP, Johnson BT. Effectiveness of yohimbine in the treatment of erectile disorder: Four meta-analytic integrations. Arch Sex Behav 1996;25:341.
8. Kunelius P, Hakkinen J, Lukkarinen O. Is high-dose yohimbine hydrochloride effective in the treatment mixed-type importance? A prospective, randomized, controlled double-blind crossover study. Urol 1997;49:441-4.
9. Mann K, Klingler T, Noe S, et al. Effect of yohimbine on sexual experiences and nocturnal tumescence and rigidity in erectile dysfunction. Arch Sex Behav 1996;25:1-16.
10. Choi HK, Seong DH, Rha KH. Clinical efficacy of Korean red ginseng for erectile dysfunction. Int J Impotence Res 1995;7:181-6.
11. Sohn M, Sikora R. Ginkgo Biloba extract in the therapy of erectile dysfunctions. J Sec Educ Ther 1991;17:53-61.
12. Cohen AJ, Bartlik B, Ginkgo biloba for antidepressant-induced sexual dysfunction. J Sex Marital The r 1998;24:139-43.
13. Aydin S, Ercan M, Caskurlu T, et al. Acupuncture and hypnotic suffestions in the treatment of non-organic male sexual dysfunction. Scand J urol Nephrol 1997;31:271-4.
14. Kho HG, Sweep CG, Chen X, et al. The use of acupuncture in the treatment of erectile dysfunction. Impot Res 1999;11:41-6.
15. Yaman LS, Kilic S, Sarica K, et al. The place of acupuncture in the management of psychogenic impotence. Eur Urol 1994;26:52-5.

   

1. Jonson WG, Jarrell MP, Chupurdia KM, Williamson DA. Repeated binge/pruge cycles in bulimia vervs role of glucose and insuline. Int J Eat Disord 1994;15:331-41.
2. Dalvit-McPhillips S. A diretary approach to bulimia. Physiol Behav 1984;33:769-75.
3. Davis C, Katzman DK, Kaptein S, et al. The prevalence of high-level exerc ise disorders: etiological implications. Compre Psychiatry 1997;38:321-6.
4. Davis C, Kennedy SH, Ravelski E, Dionne M. The role of  physical activity in the development and maintenance of eating disorders. Psychol Med 1994;24:957-67.
5. Thibault L, Roberge AG. The nutritional status of subjects with anorexia nervosa. Int J Vitam Nutr R 1987;57:447-52.
6. Abou-Saleh MT, Coppen A. The biology of folate in depression: implications for nutritional hypothes the psychoses. J Psychiatr Res 1986;20:91-101.
7. Beaumont PJ, Chambers TL, Rouse L, Abraham SF. The diet composition and nutritional knowledge patients with anorexia nervosa. J Hum Nutr 1981;35:265-73.
8. Zerbe KJ. Anorexia nervosa and bulimia nervosa. When the pursuit of bodily perfection becomes a postgrad Med 1996;99:161-4, 167-9 (review)
9. Garner DM, Garner MV, Rosen LW. Anorexia nervosa restricters who purge: implications fur subtype anorexia nervosa. Int J Eat Disord 1993;13:171-85.
10. Spitzer RL, Yanovski S, Wadden T, et al. Binge eating disorder: its further validation in a multisite st Int J Eat Disord 1993;13:137-53.
11. Drewnowski A, Halmi KA, Pierce B, et al. Talste and eating disorders. Am J Clin Nutr 1987;46:442-50.
12. Casper RC, Pandy GN, Jaspan JB, Rubenstein AH, Hormone and metabolite plasma levels after oral glucose in bulimia and healthy controls. Biol Psychiatry 1988;24:663-74.
13. Safai-Kutti S. Oral Zinc supplementation in anorexia nervosa. Acta Psychiatre Scand Suppl 1990;361:44-57.
14. Van der SDter Wallin G, Norring C, Holmgren S. Binge eating versus nonpurged eating in bulimics: is the carbohydrate craving after all? Acta Psychiatre Scand 1994;89:376-81.
15. Blouin AG, Blouin J, Bushnik T, et al. A double-blind placebo-controlled glucose challenge in bulimia nervosa: psychological effects. Biol Psychiatry 1993;33:160-8.

   

1. Michaelsson G, Juhlin L, Ljunghall K. A double blind study of the effect of zinc and oxytetracycline in vulgaris. Br J Dermatol 1977;97:561-6.
2. Cunliffe WJ, Burke B, Dobman B, Gould DJ. A double-blind trial of a zinc sulphate/citrate complex an tetracycline in the treatment of ance vulgaris. Br J Dermatol 1979;101:321-5.
3. Kligman AM, Mulls OH Jr, Leyden JJ, et al. Oral vitamin A in acne vulgaris. Preliminary report. Int Dermatol 1981;20:278-85.
4. Leung LH. Pantothenic acid deficiency as the pathogenesis of acne vulgaris. Med Hypotheses 1995;44:490-2.
5. Snider B, Dietman DF. Pyridoxine therapy for premenstrual acne flare. Arch Dermatol 1974;110:13-15 (letter).
6. Joliffe N, Rosenblum LA, Sawhill J. Effects of pyridoxine (vit B6) on resistant adolescent acne. J Inv Dermatol 1942;5:134-8.
7. Fulton JE Jr, Plewig G, Kligman AM. Effect of chocolate on acne vulgaris. Jama 1969;210:2071-4.
8. Anderson PC. Foods as the cause of ance. Am Family Phys 1971;3:102-3.
9. Gaby A. Commentary. Nutr Healing 1997;Feb:1,10-1.
10. Shality AR, Smith JR, Parish LC, et al. Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory ance vulgaris. Internat J Dermatol 1995;34:434-7.
11. Hollstrom, L Pettersson L, Hellbe L, et al. Comparison of oral treatment with zinc sulfate and placebo ance vulgaris. Br J Dermatol 1977;97:681-4.
12. Verma KC, Saini AS, Dhamija SK. Oral zinc sulphate therapy in acne vulgaris: a double-blind trial. Aced Dermatovener (Stockholm) 1980;60:337-40.
13. Dreno B, Amblard P, Agache P, et al. Low doses of zinc gluconate for inflammatory acne. Acta Dermatovener (Stockholm) 1989;69:541-3.
14. Michaelsson G. Oral zinc in acne. Acta Dermatovener (Stockholm) 1980;Suppl 89:87-93 (review).
15. Braun-Falco O, Lincke H, The problem of vitamin B6/B12 acne. A contribution on acne medicamento mmw munch med wochenschr 1976;118(6):155-60 (in German).

   

1. Russell RM, Krasinski SD, Samloff IM. Correction of impaired folic acid (Pte Glu) absorption by orally administered HCI in subjects with gastric atrophy. Am J Clin Nutr 1984;39:656.
2. Mayron LW. Portals of entry: A review. Ann Allergy 1978;40:399-405.
3. Walker WA, Isselbacher KJ. Uptake and transport of macro-molecules by the intestine. Possible role clinical disorders. Gastroenterology 1974;67:531-50.
4. Drasar BS, Shiner M, McLeod GM. Studies on the intestinal flora. I. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons. Gastroenterology 1969;56:71-9.
5. Giannella RA. Influence of gastric acidity on bacterial and parasitic enteric infections. A perspective. Intern med 1973;78:271-6.
6. Wright JV. Dr. Wrights Guide to Healing with Nutrition. New Canaan, CT: Keats Publishing, 1990, 3.
7. Suarez F, Levitt MD, Adshead J, Barkin JS. Pancreatic supplements reduce symptomatic response of healthy subjects to a high fat meal. Dig Dis Sci 1999;44:1317-21.
8. Schulz V, Hansel R. Tyler VE. Rational Phytotherapy: A Physicians Guide to Herbal Medicine. 3^rd ed Berlin: Springer, 1998, 168-73.
9. Ritter R, Schatton WFH, et al. Clinical trial on standardized cerlandine extract in patients with function epigastric complaints: Results of placebo-controlled double-blind trial. Comp Ther Med 1993;1:189-93.
10. Benninger J, Schneider HT, Schuppan D, et al. Acute hepatitis induced by greater celandine (Chelidonium majus). Gastroenterol 1999;117:1234-7.
11. Kraft K. Artichoke leaf extract-recent findings reflecting effects on lipid metabolism, liver and gastromestinal tracts. Phytomedicine 1997;4:370-8 (review).
12. Wright JV. Dr. Wrights Guide to Healing with Nutrition. New Canaan, CT: Keats Publishing, 1990, 15.
13. Murray MJ, Stein N. A gastric factor promoting iron absorption. Lancet 1968;1:614.
14. Sturniolo GC, Montino MC, Rossetto L, et al. Inhibition of gastric acid secretion reduced zinc absorption man. J Am Coll Nutr 1991;10:372-5.
15. Allison JR. The relation of hydrochloric acid and vitamin B complex deficiency in certain skin condition South Med J 1945;38:235-41.

   

1. Kemp WN. Hyperemesis gravidarum treated as a temporary adrenal cortex deficiency. Can Med Association 1933;28:389-91.
2. Kemp WN. The vomiting of pregnancy treated as a temporary relative insufficiency of maternal corticoadrenal function. Med Rec 1934;140:239-41.
3. Fischer-Rasmussen W, Kjaer SK, Dahl C, Asping U. Ginger treatment of hyperemesis gravidarum. Eu Obstet Gynecol Reprod Biol 1990;38:19-24.
4. Fulder S, Tenne M. Ginger as an anti-nausea remedy in pregnancy and the issue of safety. HerbalGra 1996;38:47-50.
5. Carlsson CPO, Axemo P, Bodin A, et al. Manual acupuncture reduces hyperemesis gravidarum: a placebo-controlled, randomized, single-blind, crossover study. J Pain Symptom Manage 2000;20:273-9.
6. Stainton MC, Neff EJ. The efficacy of SeaBands for the control of nausea and vomiting in pregnancy health Care Women Int 1994;15:563-75.
7. Belluomini J, Litt RC, Lee KA, Katz M. Acupressure for nausea and vomiting of pregnancy: a random blinded study. Obstet Gynelcol 1994;84:245-8.
8. Hyde E. Acupressure therapy for morning sickness. A controlled clinical trial. J Nurse Midwifery 1989;34:171-8.
9. Chan NN. Thyroid function in hyperemesis gravidarum. Lancet 1999;353:2243 (letter).
10. Signorello LB, Harlow BL, Wang SP, Erich MA. Saturated fat intake and the risk of severe hyperemes gravidarum. Am J Epidemiol 1996;143 (11 Suppl):S25 (abstract #97).
11. Sahakian V, Rouse D, Sipes S, et al. Vitamin B6 is effective therapy for nausea and vomiting of pregnancy: a randomized, double-blind placebo-controlled study. Obstet Gynecol 1991;78:33-6.
12. Vutyavanich T, Wongtra-ngan S, Ruangsri R. Pyridoxine for nausea and vomiting of pregnancy: a randomized, double blind, placebo-controlled trial. Am J Obstet Gynecol 1995;173:881-4.
13. Merkel RL. The use of menadione bisulfite and ascorbic acid in the treatment of nauseas and vomiting pregnancy. Am J Obstet Gynecol 1952;64:416-8.

   

1. Hartoma TR, Sotaniemi EA, Maattanen J. Effect of zinc on some biochemical indices of metabolism. Metab 1979;23:294-300.
2. Weismann K, Roed-Petersen J, Hjorth N, Kopp H. Chronic zinc deficiency syndrome in a beer drinke with a Billroth II resection. Int J Dermatol 1976;15:757-61.
3. Wolf WR, Holden J, Greene FE. Daily intake of zinc and copper from self selected diets. Fed Proc 1977;36:1175.
4. Paynter OE, Burin GJ, Jaeger RB, Gregorio CA. Goitrogens and thyroid follicular cell neoplasia: evide for a threshold process. Regul Toxicol Pharmacol 1988;8:102-19 (review).
5. McMillan M, Spinks EA, Fenwick GR. Preliminary observations on the effect of dietary Brussels sprout thyroid function. Hum Toxicol 1986;5:15-9.
6. Biassoni P, Ravera G, Bertocchi J, et al. Influence of dietary habits on thyroid status of a nomadic per the Bororo  shepherds, roaming a central African region affected by severe iodine deficiency. Eur J Endocrinol 1998;138:681-5.
7. Boyages SC. Iodine deficiency disorders. J Clin Endocrinol Metab 1993;77:587-91.
8. Galland L. Biochemical abnormalities in patients with multiple chemical sensitivities. Occup Med 1987;2:713-20 (review).
9. Robins JM, Cullen MR, Connors BB, Kayne RD. Depressed thyroid indexes associated with occupation exposure to inorganic lead. Arch Intern Med 1983;143:220-4.
10. Thilly CH, Swennen B, Bourdoux P, et al. The epidemiology of iodine-deficiency disorders in relation goitrogenic factors and thyroid-stimulation-hormonr regulation. Am J Clin Nutr I 1993;57(2 Suppl):267-70S.
11. Delange F. Risks and benefits of iodine supplementation. Lancet 1998;351:923-4.
12. Cntempre B, Dumont JE, Ngo B, et al. Effect of selenium supplementation in hypothyroid subjects of iodine and selenium deficient area: the possible danger of indiscriminate supplementation of iodine-def subjects with selenium. J Clin Endocrinol Metab 1991;73:213-5.
13. Chow CC, Phillips DIW, Lazarus JH, Parkes AB. Effect of low dose iodide supplementation on thyroid function in potentially susceptible subjects: are dietary iodide levels in Britain acceptable? Clin Endocrin 1991;34:413-6.
14. Stewart JC, Vidor GI. Thyrotoxicosis induced by iodine contamination of food: a common unrecognized condition? Br Med J 1976;1:372-5.
15. Fujimoto S, Indo Y, Higashi A, et al. Conversion of thyroxine into tri-iodothyronine in zinc deficient liver. J Pediatr Gastroenterol Nutr 1986;5:799-805.

   

1.    Amostegui Azcue JM, Ferri Morales A, Lillo De La Quintana C, Serra Llosa ML. Urinary incontinence and other pelvic floor damages: ethilogy and prevention strategies. Rev Med Univ Navarra. 2004 Oct-Dec;48(4):18-31. Review. Spanish.
2.    Walters MD. Pelvic floor disorders in women: an overview. Rev Med Univ Navarra. 2004 Oct-Dec;48(4):9-12, 15-7. Review.
3. Vlk R. Chmel R. Diagnostic algorithms in female urinary incontinence. Cas Lek Cesk. 2005;144(2):98-101. Review. Czech.
4. Chmel R, Novackova M, Vlk R, Horicick L. Epidemiological aspects of the female urinary incontinence. Cas Lek Cesk. 2005;144(2):95-7. Review. Czech.
5. Artibani W.  Cerruto MA. The role of imaging in urinary incontinence. BJU Int. 2005 Apr;95(5):699-703. Review.
6. Kirwin JL, Goren JL. Duloxetine: a dual serotonin-norepinephrine reuptake inhibitor for treatment of major depressive disorder. Pharmacotherapy. 2005 Mar;25(3):396-410. Review.
7. Ben Meir A, Schenker JG, Ezra Y. Cesarean section upon request: is it appropriate for everybody? J Perinat Med. 2005;33(2):106-11. Review.
8. Atherton MJ, Stanton SL. The tention-free vaginal tape reviewed: an evidence-based review from inception to current status. BJOG. 2005 May;112(5):534-46. Review. No abstract available.
9. Barber MD, Dowsett SA, Mullen KJ, Viktrup L. The impact of stress urinary incontinence on sexual activity in women. Cleve Clin J Med. 2005 Mar;72(3):225-32. Review.
10. Pender JR, Pories WJ. Epidemiology of obesity in the United States. Gastroenterol Clin North Am. 2005 Mar;34(1):1-7 Review.
11. Goldtein RE, Westropp JL. Urodynamic testing in the diagnosis of small animal micturition disorders. Clin Tech Small Anim Pract. 2005 Feb;20(1):65-72. Review.
12. Christofi N, Hextall A. Which procedure for incontinence? J Br Menopause Soc. 2005 Mar;11(1):23-7. Review.
13. Marques Queimadelos A, Soura Escandon A, Garcia-Fantini M, Cimadevila Garcia A, Lema Grille J. Female urinary stress in incontinence: transobsturator techinique. Rev Med Univ Navarra. 2004 Oct-Dec;48(4):62-9. Review. Spanish.
14. Rioja Zuazu J, Robles Garcia JE, Saiz Snasi A, Regojo Baloba M, Fermandez-Montero M, Lopez Ferrandiz, J, Rosell Costa D, Zudaire Bergera JJ, Berian Polo M. Urinary incontinence surgery: TVT procedure. Rev Med univ Navarra. 2004 Oct-Dec;48(4):56-61. Review. Spanish.
15.  Bergera Zuadaire JJ, Garcia Robles JE, Saiz Snasi A, Rioja Zuazu J, Regojo Balboa JM, Fernandez Montero JM, Lopez Ferrandiz J, Rosell Costa D, Berian Polo M. Female incontinence: urodynamic evaluation. Rev Med Univ Navarra. 2004 Oct-Dec;48(4):32-6. Review. Spanish.

   

1. Rothstein E. Edwards K. Health burden of pertussis in adolescents and adults. Pediatr Infect Dis J. 2005 May;24(5 Suppl):S44-7. Review. 
2. Hautmann RE, Stein JP. Neobladder with prostatic capsule and seminal-sparing cystectomy for bladder cancer: a step in the wrong direction. Urol Clin North Am. 2005 May;32(2):177-85. Review.
3.   Kessler TM, Burkhard FC, Ctuder UE. Clinical indications and outcomes with nerve-sparing cystectomy in patients with bladder cancer.
4.  Pender JR, Pories WJ. Epidemiology of obesity in the United States. Gastroenterol Clin North Am. 2005 Mar;34(1):1-7. Review.
5.  Kavia R, Mumtaz F. Overactive bladder. JR Soc Health. 2005 Jul;125(4):176-9. Review.
6.  Berrry A. A child with daytime wetting: three case studies. Urol Nurs. 2005 Jun:25(3):202-5. Review. No abstract available.
7.  Dodd ME, Langman H. Urinary incontinence in cystic fibrosis. J R Soc Med. 2005;98 Suppl 45:28-36. Review. No abstract available.
8.  Assessment and management of urinary incontinence. Nurse Pract. 2005 Jul;30(7):32-3, 36-43; quiz 43-5. Review. No abstract available.
9.  Simon P., Zerbib M, Deebre B, Peyromaure M. Reesults of the AMS 800 artificial urinary sphincter in men, based on a series of 47 patients. Prog Urol. 2005 Apr;15(2):244-9. Review. French.
10.  Johansen TE. Radical therapy for prostate cnacer in Norway. Tidsskr Nor Laegeforen. 2005 Jun 16;125(12):1658-60. Review. Norwegian.
11.  Bonniaud V, Railbaut P, Guyatt G, Amarenco G, Parratee B. Symptom and quality of life assessment in urinary disorders. Ann Readapt Med Phys. 2005 Jul;48(6):392-403. Epub 2005 Apr 18. Review. French.
12.  Fletcher K. Elimination: Geriatric Self-Learning Module. Medsurg Nurs. 2005 Apr;14(2):127-31. Review. No abstract available.
13.  Quek ML, Penson DF. Quality of life in patients with localized prostate cancer. Urol Oncol. 2005 May-Jun;23(3):208-15. Review.
14.  Hampton S. Improtance of the appropriate selection and use of continence pads. Br J Nurs. 2005 Mar 10-23;14(5):265-6. 268-9. Review. 
15. Kovacs T, Szirmai I, Papp M. Clinico-pathology and differential diagnosis of Binswanger’s disease. Ideggyogy Sz. 2005 Mar 20;58(3-4):78-87. Review. Hungarian.

   

1. Bindoli A, Valente M, Cavallini L. Inhibitory action of quercetin on xanthine oxidase and xanthine dehydrogenase activity. Pharmacol Res Commun 1985;17:831-9.
2. Busse W, Kopp D, Middleton E. Flavonoid modulation of human neutrophil function. J Allergy Clin Immunol 1984;73:801-9.
3. Blau LW. Cherry diet control for gout and arthritis. Tex Rep Biol Med 1950;8:309-11.
4. Leonen H, Eshuis H, Lowik M, et al. Serum uric acid correlates in elderly men and women with specia reference to body composition and diatary intake (Dutch Nutrition Surveillance System). J Clin Epidemial 1990;43:1297-303.
5. Oster KA. Xanthine oxidase and folic acid. Ann Interm Med 1977;87:252-3.
6. Boss GR, Ragsdale  RA, Zettner A, Seegmiller JE. Failure of folic acid (pteroylglutamic acid) to affect hyperuricemia. J Lab Clin Med 1980;96:783-9.
7. Stein HB, Hasan A, Fox IH. Ascorbic acid-induced uricosuria: a consequence of megavitamin therapy Intern Med 1976;84:385-8.
8. Ralston SH, Capell HA, Sturrock RD. Alcohol and response to treatment of gout. BMJ 1988;296:1641.
9. Scott JT. Alcohol and gout. BMJ 1989;298:1054.
10. Emmerson BT. Effect of oral fructose on urate production. Ann Rheum Dis 1974;33:276-80.

   

1. Perloff WH. Treatment of the menopause. Am J Obstet Gynecol 1949;58:684-94,
2. Gozan HA. The use of vitamin E in treatment of the menopause. NY State j Med 1952;52:1289.
3. Christy CJ. Vitamin E in menopause: Preliminary report of experimental and clinical study. Am J Obst Gynecol 1945;50:84.
4. Finkler RS. The effect of vitamin E in the menopause. J Clin endocrinol Metab 1949;9:89-94.
5. Baird DD, Umbach Dm, Landsedell L, et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 1995;80:1685-90.
6. Cassidy A, Bingham S, Setchell KD. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994;60:333-40.
7. Kinght DC, eden JA. A review of the clinical effects of phytoestrogens. Obstet Gynecol 1996;87:897-8 (review).
8. Albertazzi P, Pansini F, Boanaccorsi G, et al. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 1998;91:6-11.
9. Albertazi P, Pansini F, Bottazzi G, et al. Dietary soy supplementation and phytoestrogen levels. Obs Gynecol 1999;94:229-31.
10. Brezinski A, Adlercreutz h, Shaoul R, et al. Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause 1997;4:89-94.
11. Ivarsson T, Spetz AC, Hammar M. Physical exercise and vasomotor symptoms in postmenopausal women. Mauritas 1998;29:139-46.
12. Hammar M, Berg G, Lindgren R. Does physical exercise influence the frequency of postmenopausal has flushes? Acta Obstet Gynecol Scand 1990;69:409-12.
13. Slaven L, Lee C. Mood and symptom reporting among middle-aged women: the relationship between menopausal status, hormone replacement therapy, and exercise participation. Health Psychol 1997;16:8.
14. Staropoli CA, Flaws JA, Bush TL, Moulton AW. Predictors of menopausal hot flashes. J Womens Health 1998;7:1149-55.
15. Greenberg G, Thompson SG, Meade TW. Relation between cigarette smoking and use of hormonal replacement therapy for menopausal symptoms. J Epidemiol Cummunity Health 1987;41:26-9.

   

1. Christensen L. Psychological distress and diet-effects of sucrose and caffeine. J Applied Nutr 1988;40:1651-50.
2. Greden JF, Fontaine P, Lubestsky M, Chamberlin K. Anxiety and depression associated with caffeinism among psychiatric inpatients. Am J Psychiatry 1978;135:963-6.
3. Gilliland K, Bullock W. Caffeine: a potential drug of abuse. Adv Alcohol Subst Abuse 1983-84;3:53-7.
4. Weber B, Schweiger U, Deuschle M, Heuser I. Major depression and impaired glucose tolerance. Exp Endocrinol Diabetes 2000;108:187-90.
5. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infraction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigato Engl J Med 1996;335:1001-9.
6. Puri BK, Counsell SJ, Richardson AJ, Horrobin DF. Eicosapentaenoic acid in treatment-resistand depression. Arch Gen Psychiatry 2002;59:91-92 (Letter).
7. Martinsen EW. Benefits of exercise for the treatment of depression. Sports Med 1990;9:380-9.
8. Martinsen EW, Medhus A, Sandivik L. Effects of aerobic exercise on depression: a controlled study. 1985;291:109.
9. Blumenthal JA, Babyak MA, Moore KA, et al. Effects of  exercise training on older patients with major depression. Arch Intern Med 1999;159:2349-56.
10. Penninx BW, Guralnik JM, Ferrucci L, et al. Vitamin B(12) deficiency and depression in physically disabled older women: epidemiologic evidence from the Womens health and Aging Study. Am J Psychi 2000;157:715-21.
11. Holmes JM. Cerebral manifestations of vitamin B12 deficiency. J Nutr Med 1991;2:89-90.
12. Ellis FR, Nasser S. A pilot study of vitamins B12 in the treatment of tiredness .Br J Nutr 1973;30:277-8.
13. Reynolds E, Preece JM, Bailey J, Coppen A. Folate deficiency in depressive illness. Br J Psychiatry 1970;117:287-92.
14. Coppen A, Chaudrhy S, Swade C. Folic acid enhances lithium prophylxis. J Affect Disord 1986;10:9-10.
15. Di Palma C, Urani R, Agricola R, et al. Is methylfolate effective in relieving major depression in chrom alcoholics? A hypothesis of treatment. Curr Ther Res 1994;55:559-67.

   

1. Blumenthal M, Busse WR, Goldberg A, et al. (eds.). The Complete German Commission E Monographs Therapeutic Guide to Herbal Medicines. Austin, TX: American Botanical Council and Boston: Integrative Medicine Communications, 1998,231.
2. Blumenthal M, Busse WR, Goldberg A, et al. (eds.). The Complete German Commission E Monographs Therapeutic Guide to Herbal Medicines. Austin, TX: American Botanical Council and Boston: Integrative Medicine Communications, 1998, 149.
3. Kreysel HW, Nissen HP, Enghofer E. A possible role of lysosomal enzymes in the pathogenesis of various and the reduction in their serum activity by Venostasin. Vasa 1983;12:377-82.
4. Capelli R, Nicora M, Di Perri T, Use of extract of Rescus aculeatus in venous desease in the lower limb Drugs Exp Clin Res 1988;14:277-83.
5. Brinkhaus B, Linder M, Shcuppan D, Hahn EG. Chemical, pharmacological and clinical profile of the East Asian medical plant Centella asiatica. Phytomed 2000;7:427-48.
6. Sohn C, Jahnichen C, Bastert G. (Effectiveness of beta-hydroxyethylrutoside in patients with varicose veins in pregnancy). Zentralbl Gynakol 1995;117:190-7 (in German).
7. Royer RJ, Schmidt CL. (Evaluation of venotropic drugs by venous gas plethysmography. A study of procyanidolic oligomers). Sem Hop 1981;57:2009-13 (in French).
8. European Scientific Cooperative on Phytotherapy. Hamamelidis folium (Hamamelis leaf). ESCOP Monographs on the Medicinal Uses of Plant Drugs. Exeter, UK: ESCOP, 1997.

 

   

1. Sirsi M. Antimicrobial action of vitamin C on M. tuberculosis and some other pathogenic organisms. In J Med Sci 1952;6:252-5.
2. Axelrod DR, Ascorbic acid and urinary ph. JAMA 1985;254:1310-1.
3. Hussey GD, Klein M. A randomized, controlled trial of vitamin A in children with severe measles. N J Med 1990;323:160-4.
4. Chandra BK. Effect of vitamin and trace-element supplmenetation on immune responses and infect elderly subjects. Lancet 1992;340:1124-7.
5. Avorn J. Monane M, Gurwitz JH, et al. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA 1994;271:751-4.
6. Dignam R, Ahmed M, Denman S, et al. The effect of cranberry juice on UTI rates in a long term carry facility. J Am Geriatr Soc 1997;45:S53.
7. Walker EB, Barney DP, Mickelsen JN, et al. Cranberry concentrate: UTI prophylaxis. J Family Pract 1997;45:167-8.
8. Sobota AE. Inhibition of bacterial adherence by cranberry juice: Potential use for the treatment of urinary tract infections. J Urol 1984;131:1013-6.
9. MacGregor RR. Alcohol and immune defense. JAMA 1986;256:1474.
10. Barone J, Herbert JR, Reddy MM. Dietary fat and natural-killer-cell activity. Am J Clin Nutr 1989;50:85-7.
11. Horesh AJ. Allergy and infection. Proof of infectious etiology. J Asthma Res 1967;4:269-82.
12. Rudolph JA. Allergy as a cause of frequent recurring colds and coughs in children. Dis Chest 1940;6:100.
13. Berman BA, Pseudomononucleosis of allergic origin: a new clinical entity. Ann Allergy 1964;22:403-5.
14. Randolph TG, Hettig RA. The coincidence of allergic disease, unexplained fatigue, and lymphadenopa possible diagnostic confustion with infectious mononucleosis. Am J Med Sci 1945;209:306-14.
15. Mori S, Ojima Y, Hirose T, et al. The clinical effect of proteolyc enzyme containing bromelain and try on urinary tract infection evaluated by double blind method. Act Obstet Gynaecol Jpn 1972;19:147-53.

   

1. Kremer JM, Lawrence DA, Jubiz W, et al. Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects. Arthritis Rheum 1990;33:810-20.
2. Hafstrom I, Ringertz B, Gyllenhammar h, et al. Effects of fasting on disease activity, neutrophil fun fatty acid composition, and leukotriene biosynthesis in patients with rheumatoid arthritis. Arthritis Rheu 1988;31:585-92.
3. Skoldstam L, Magnusson KE. Fasting, intestinal permeability, and rheumatoid arthritis. Rheum Dis C North Am 1991;17:363-71 (review).
4. KjeldsenKragh J, Haugen M, Borchgrevink CF, et al. Controlled trial of fasting and oneyear vegetarian diet in rheumatoid arthritis. Lancet 1991;338:899-902.
5. Kjeldsen-Kragh J, Haugen M, Borchgrevink CF, Forre O. Vegetarian diet for patients with rheumatism arthritis-status: two years after introduction of the diet. Clin Rhemuatol 1994;13:475-82.
6. Seignalet J. Diet, fasting, and rheumatoid arthritis. Lancet 1992;339:68-9. (letter).
7. Levy JA, Ibrahim AB, Shirai T, et al. Dietary fat affects immune response, production of antiviral fact and immune complex disease in NZP/NZW mice. Proc Natl Acad Sci 1982;79:1974-8.
8. Jacobsson I. Lindgarde F, Manthorpe R, et al. Correlation of fatty acid composition of adipose tissue and serum phosphatidyl choline and serum concentrations of micronutrients with disease duration in rheumatoid arthritis. Ann Rheum Dis 1990;49:901-5.
9. Lucas CP, Power L. Dietary fat aggravates active rheumatoid arthritis. Clin Res 1981;29:754A (abstract).
10. Skoldstam L. Fasting and vegan diet in rheumatoid arthritis. Scand J Rheumatol 1987;15:219-21.
11. Nenonen M, Helve T, Hanninen O. Effects of uncooked vegan food – living food – on rheumatoid arth a three month controlled and randomized study. Am J Clin Nutr 1992;56:762 (abstract #48).
12. Warmbrand M. How Thousands of My Arthritis Patients Regained Their Health. New York: Arco Publish 1974.
13. Panush RS, Carter RL, Katz P, et al. Diet therapy for rheumatoid arthritis. Arthrit Rheum 1983;26:46-71.
14. KjeldsenKragh J, haugen M, Borchgrevink CF, et al. Controlled trial of fasting and oneyear vegetarian in rheumatoid arthritis. Lancet 1991;338:899-902.
15. Linos A, Kaklamani VG, Koukmantaki Y, et al. Dietary factors in relation to rheumatoid arthritis: a role olive and cooked vegetables. Am J Clin Nutr 1999;70:1077-82.

   

1. Haimovici R, Roussel TJ. Treatment of gonococcal conjunctivitis with single-dose intramuscular ceftriaxone. Am J Ophthalmol 1989;107:511-4.
2. Ullman S, Roussel TJ, Forster RK. Gonococcal keratoconjunctivitis. Surv Ophthalmol 1987;32:199-208.
3. Wagner RS. Results of a survey of children with acute bacterial conjunctivitis treated with trimethoprim-polymyxin B ophthalmic solution. Clin Ther 1995;17:875-81.
4. Rayner SA, Buckley RJ. Ocular chloramphenicol and aplastic anaemia. Is there a link? Drug Saf 1996;14:273-6.
5. Browning DJ, Proia AD. Ocular rosacea. Surv Ophthalmol 1986;31:145-58.
6. Dawson CR. Chlamydial infections: inclusion conjunctivitis. In: Fraunfelder FT, Roy FH, Grove J, eds. Current ocular therapy 4. Philadelphia: Saunders, 1995:59-61.
7. Viswalingam ND, Darougar S. Chlamydial infections: trachoma. In: Fraunfelder FT, Roy FH, Grove J, eds. Current ocular therapy 4. Philadelphia: Saunders, 1995:61-3.
8. Viswalingam ND, Wishart MS, Woodland RM. Adult chlamydial ophthalmia (paratrachoma). Br Med Bull 1983;39:123-7.
9. Darougar S, Monnickendam MA, Woodland RM. Management and prevention of ocular viral and chlamydial infections. Crit Rev Microbiol 1989;16: 369-418.
10. Postema EJ, Remeijer L, van der Meijden WI. Epidemiology of genital chlamydial infections in patients with chlamydial conjunctivitis; a retrospective study. Genitourin Med 1996;72:203-5.
11. Garland SM, Malatt A, Tabrizi S, Grando D, Lees MI, Andrew JH, et al. Chlamydia trachomatis conjunctivitis. Prevalence and association with genital tract infection. Med J Aust 1995;162:363-6.
12. Azar MJ, Dhaliwal DK, Bower KS, Kowalski RP, Gordon YJ. Possible consequences of shaking hands with your patients with epidemic keratoconjunctivitis. Am J Ophthalmol 1996;121:711-2.
13. Noble S, McTavish D. Levocabastine. An update of its pharmacology, clinical efficacy and toler